Veeva Systems Inc. Class A

Good afternoon and welcome to VIVA's fiscal 2023 fourth quarter and full year earnings conference call for the quarter and year ended January 31st, 2023. As a reminder, we posted prepared remarks on VIVA's investor relations website just after 1 p.m. Pacific today. We hope you've had a chance to read them before the call. Today's call will be used primarily for Q&A. With me today for Q&A are Peter Gassner, our chief executive officer, Paul Shawa, EVP commercial strategy, and Brent Bowman, our Chief Financial Officer. During this call, we may make forward-looking statements regarding trends, our strategies, and the anticipated performance of the business, including guidance regarding future financial results. These forward-looking statements will be based on our current views and expectations and are subject to various risks and uncertainties. Our actual results may differ materially. Please refer to the risks listed in our earnings release and the risk factors included in our most recent filing on Form 10Q. Forward-looking statements made during the call are being made as of today, March 1, 2023, based on the facts available to us today. If this call is replayed or viewed after today, the information presented during the call may not contain current or accurate information. VIVA disclaims any obligation to update or revise any forward-looking statements. We may discuss our guidance on today's call, but we will not provide any further guidance or updates on our performance during the quarter unless we do so in a public forum. On the call, we may also discuss certain non-GAAP metrics that we believe aid in the understanding of our financial results. A reconciliation to comparable GAAP metrics can be found in today's earnings release and in the supplemental investor presentation, both of which are available on our website. With that, thank you for joining us, and I'll turn the call over to Peter.

Thank you, Eto, and welcome everyone to the call. We had a strong finish to the year with results ahead of our guidance for the quarter end year, thanks to great execution by the Viva teams across all areas. We're early in the significant industry cloud opportunity, and we're executing well. It was a breakout year for clinical data management, and we saw great traction in newer areas such as safety, link, and compass. Our innovation engine is strong and our strategic partnerships with the industry are increasing. We issued guidance for fiscal 24 and initial guidance for fiscal 25 to provide context for the one-time revenue impacts to 2024 related to TFC. Normalizing for TFC and FX, we expect revenue to grow about 15% in fiscal 24 and at least 15% in fiscal 25.

At this point, we'll open the call to your questions.